The study found that people who previously had mild or asymptomatic infection had enhanced protection against more infectious mutated variants that emerged in U.K., South Africa.
Risk from COVID-19 variants remains after first Pfizer shot: study
The study found that people who previously had mild or asymptomatic infection had enhanced protection against more infectious mutated variants that emerged in U.K., South Africa.